COSM
Cosmos Health Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.27
+2.59%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $20.9M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$0.10
- EPS estimate
- -$0.10
- Revenue actual
- $19.3M
- Revenue estimate
- $19.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -575.0%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026